StreetAlpha
13F holdings · Q2 2026

Carlyle Group

Washington, DC · files as Carlyle Group Inc.
Holdings as of Jun 30, 2026Filed Aug 7, 2026Next filing due Nov 16, 2026CIK 1527166

Carlyle Group reported 19 stocks worth $10B in its 13F filing for Q2 2026, filed Aug 7, 2026. Its largest holdings are MDLN (73.8%), SARO (25.3%) and PHAT (0.4%). Compared with Q1 2026, the fund opened new positions in REPX, NBIS and METC, added to SPWR and HOOD, trimmed INVH and QTTB and sold out of CUBE, HTFL and SYRE.

Reported value$10B−5.8% vs last quarter
Stocks held193 new · 4 sold out
Top 5 weight99.8%very concentrated
Turnover0%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MDLN
Medline Inc
$7.4B73.8%187MNo change3 of 8
2
SARO
Standardaero Inc
$2.5B25.3%84.6MNo change7 of 8
3
PHAT
Phathom Pharmaceuticals Inc
$37.9M0.4%3.5MNo change8 of 8
4
INVH
Invitation Homes Inc
$20M0.2%663K−1,200 (−0%)8 of 8
5
PONY
Pony AI Inc
$16.4M0.2%2.4MNo change7 of 8
6
GETYQ
Getty Images Holdings Inc
$5.4M0.1%6.2MNo change8 of 8
7
SPRB
Spruce Biosciences Inc
$2.1M0.0%39KNo change4 of 8
8
SPWR
Complete Solaria Inc
$1.6M0.0%2.3M+1.9M (+441%)8 of 8
9
ACET
Adicet Bio Inc
$1.6M0.0%184KNo change3 of 8
10
FWRD
Forward Air Corp
$1.4M0.0%107KNo change5 of 8
🔒 9 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q1 2026, gone in Q2 2026
StockValue last quarterShares sold
CUBE
Cubesmart
$8.1M221K
HTFL
Heartflow Inc
$497K20K
SYRE
Spyre Therapeutics Inc
$485K9,620
XCUR
Exicure Inc
$240K56K

Reported value

last 8 quarters
$954MQ3 '24
$4.1BQ4 '24
$3.8BQ1 '25
$5BQ2 '25
$4.3BQ3 '25
$13.6BQ4 '25
$10.6BQ1 '26
$10BQ2 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q2 2026

straight from the SEC
FiledFormQuarter
Aug 7, 202613F-HRQ2 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Carlyle Group 13F FAQ

What does Carlyle Group own?

Carlyle Group reported 19 stocks worth $10B in its 13F filing for Q2 2026, filed Aug 7, 2026. Its largest holdings are MDLN (73.8%), SARO (25.3%) and PHAT (0.4%). The table above lists every position in the filing (the top 10 without an account).

What did Carlyle Group buy and sell in Q2 2026?

Compared with Q1 2026: 3 new positions, 2 added to, 2 trimmed and 4 sold out. New positions include REPX, NBIS and METC. It sold all of CUBE, HTFL and SYRE.

When will Carlyle Group file its next 13F?

Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.

How much is Carlyle Group's portfolio worth?

The Q2 2026 filing reports $10B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.